Olive Rock Partners uses the Cedro strategy to drive growth at HealthPlus IVF

UAE — Olive Rock Partners (ORP), a leading growth-focused investor in the Gulf’s healthcare sector, has announced a strategic partnership with Cedro Strategy, a specialist healthcare advisory and transformation firm.

The collaboration aims to accelerate the growth and modernization of HealthPlus IVF & Women’s Health Abu Dhabi, reinforcing its role as a regional leader in fertility and women’s health services.

This partnership marks a major step in advancing clinical excellence, operational efficiency, and innovation in one of the Middle East’s most rapidly evolving medical markets.

It follows ORP’s recent strategic realignment with global healthcare platform M42, under which Olive Rock Partners acquired full ownership of HealthPlus IVF & Women’s Health Abu Dhabi earlier this year.

That acquisition has paved the way for renewed investment, a sharper strategic focus, and transformative growth in fertility services across the UAE.

The initiative also aligns with Abu Dhabi’s broader vision to position itself as a global hub for reproductive medicine.

It supports the Department of Health’s commitment to attracting world-class expertise, deploying advanced technologies, and fostering continuous healthcare innovation.

Through this collaboration, HealthPlus IVF & Women’s Health is set to play a central role in realizing Abu Dhabi’s ambition to become the “IVF capital of the world,” by delivering exceptional clinical outcomes, enhancing patient experiences, and attracting fertility tourism to the emirate.

Commenting on the announcement, Abdullah Shahin, Founding Partner at Olive Rock Partners, stated that HealthPlus IVF & Women’s Health offers a unique opportunity to create a next-generation platform for fertility and women’s health in Abu Dhabi and the wider region.

He noted that the partnership with Cedro Strategy reflects a shared commitment to disciplined execution, innovation, and long-term value creation.

Shahin emphasized that the company’s vision aligns completely with Abu Dhabi’s ambition to attract leading global capabilities in fertility care and expressed confidence in unlocking the full potential of the platform.

Rayan Salam, founder and CEO of Cedro Strategy, said his team is excited to collaborate with Olive Rock Partners at this pivotal stage.

He explained that Cedro Strategy’s focus is on building a differentiated healthcare platform that achieves superior clinical results, delivers an elevated patient journey, and adopts a future-ready model for fertility and women’s health.

Salam added that the firm is introducing advanced technologies, digital capabilities, and international expertise to ensure HealthPlus IVF & Women’s Health provides some of the world’s most advanced fertility services.

As part of the post-acquisition governance structure, Rayan Salam will assume the position of Chairman of the Board for HealthPlus IVF & Women’s Health, providing strategic oversight and guiding the transformation agenda to align operations with long-term growth objectives.

Both Olive Rock Partners and Cedro Strategy reaffirm their commitment to maintaining continuity, stability, and uninterrupted operations throughout this transition.

HealthPlus IVF & Women’s Health will continue offering its full range of services without disruption, with all physicians, nurses, embryologists, and clinic teams remaining fully supported.

Patients can expect the same exceptional standards of care and a seamless experience as the transformation takes shape.